This inventor holds 1 USPTO granted patent. Top assignee: The Cleveland Clinic Foundation. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Kevin Sun: Innovator in Neuroscience
Introduction
Kevin Sun is a prominent inventor based in Solon, OH (US). He has made significant contributions to the field of neuroscience through his innovative research and patents. His work focuses on understanding the role of specific genes in neuronal function and their implications for treating neurological disorders.
Latest Patents
Kevin Sun holds a patent for "Transgenic mice with inducible neuron-specific inactivation of HuR gene and method of screening." This patent describes non-human transgenic animals that either under-express or do not express the Hu Antigen R (HuR) gene in certain neurons. These animals are valuable for screening drugs and therapies, particularly those aimed at treating conditions such as Amyotrophic Lateral Sclerosis (ALS).
Career Highlights
Kevin Sun is affiliated with the Cleveland Clinic Foundation, where he conducts his research. His work has garnered attention for its potential to advance therapeutic strategies in neuroscience. He has successfully developed innovative models that can aid in understanding complex neurological conditions.
Collaborations
Kevin collaborates with esteemed colleagues, including Xiaoxia Li and Tomasz Herjan. Their combined expertise enhances the research efforts at the Cleveland Clinic Foundation, fostering an environment of innovation and discovery.
Conclusion
Kevin Sun's contributions to neuroscience through his patent and research at the Cleveland Clinic Foundation highlight his role as a key innovator in the field. His work promises to pave the way for new treatments for neurological disorders.